Trade Summary

6 days ago, ZANTE GREG, serving as Chief Financial Officer at Viking Therapeutics, Inc. (VKTX), sold 21,217 shares at $33.47 per share, for a total transaction value of $710,141.48. Following this transaction, ZANTE GREG now holds 212,204 shares of VKTX.

This sale represents a 9.09% decrease in ZANTE GREG's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, July 29, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, July 30, 2026 (accepted Jul 29, 8:06 PM ET), 1 day after the trade was made.

Viking Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.